Publications

Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation.

Rollier CS. et al, (2022), Vaccine

Viral vector vaccines.

McCann N. et al, (2022), Curr opin immunol, 77

Divergent trajectories of antiviral memory after SARS-CoV-2 infection.

Tomic A. et al, (2022), Nat commun, 13

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.

COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. Electronic address: julian.knight@well.ox.ac.uk None. and COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium None., (2022), Cell, 185, 916 - 938.e58

Distinct patterns of whole blood transcriptional responses are induced in mice following immunisation with adenoviral and poxviral vector vaccines encoding the same antigen.

Sheerin D. et al, (2021), Bmc genomics, 22

Publisher Correction: Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus.

Lin G-L. et al, (2021), Nat commun, 12

Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus.

Lin G-L. et al, (2021), Nat commun, 12

Host gene signature shows promise to distinguish bacterial and viral infections.

Channon-Wells S. and O'Connor D., (2021), Lancet digit health, 3, e465 - e466

Divergent trajectories of antiviral memory after SARS-Cov-2 infection

Tomic* A. et al, (2021)

Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

Barrett JR. et al, (2021), Nat med, 27

Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

Ewer KJ. et al, (2021), Nat med, 27

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

Ahern DJ. et al, (2021)

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.

Emary KRW. et al, (2021), Lancet, 397, 1351 - 1362

Symptom study app provides real-world data on COVID-19 vaccines

Drury RE. and O'Connor D., (2021), The lancet infectious diseases

Identification of novel locus associated with coronary artery aneurysms and validation of loci for susceptibility to Kawasaki disease.

Hoggart C. et al, (2021), Eur j hum genet

RNA2HLA: HLA-based quality control of RNA-seq datasets

Chelysheva I. et al, (2021), Briefings in bioinformatics

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

Voysey M. et al, (2021), Lancet, 397, 881 - 891

Editorial: Vaccination of Special Populations: Protecting the Vulnerable.

O'Connor D. et al, (2021), Front immunol, 12

Variation in hospital admission in febrile children evaluated at the Emergency Department (ED) in Europe: PERFORM, a multicentre prospective observational study.

Borensztajn DM. et al, (2021), Plos one, 16